<unk>  often has a poor prognosis. Typical survival despite surgery is between 12 and 21 months depending on the stage of disease at diagnosis with about 7.5% of people surviving for 5 years. Women, young people, people with low-stage cancers, and people with epithelioid cancers have better prognoses. Negative prognostic factors include sarcomatoid or biphasic histology, high platelet counts (above 400,000), age over 50 years, white blood cell counts above 15.5, low glucose levels in the pleural fluid, low albumin levels, and high fibrinogen levels. Several markers are under investigation as prognostic factors, including nuclear grade, and serum c-reactive protein. Long-term survival is rare. Pericardial<unk>  has a 10-month median survival time. In peritoneal<unk> , high expression of WT-1 protein indicates a worse prognosis.
Mesothelioma
Hemangioendothelioma
Epithelioid hemangioendothelioma
Pulmonary sclerosing pneumocytoma
Large-cell lung carcinoma
Giant-cell carcinoma of the lung
Sarcomatoid carcinoma of the lung
Sarcoma